EGTX · Egetis Therapeutics AB (publ) · Insider Trading
Transactions in Egetis Therapeutics AB (publ) securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-09-02 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 594 Quantity | 7.771854 SEK | Current |
| 2026-08-31 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 1099 Quantity | 0 SEK | Current |
| 2026-08-31 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 1099 Quantity | 0 SEK | Current |
| 2026-08-31 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 1099 Quantity | 0 SEK | Current |
| 2026-08-31 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 2198 Quantity | 0 SEK | Current |
| 2026-05-13 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 158928 Quantity | 6.5 SEK | Current Ändrade avyttring från BTA till vanlig aktie |
| 2026-05-11 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 264880 Quantity | 0 SEK | Current Ändrade avyttring från BTA till vanlig aktie |
| 2026-05-11 | Nils Hallén Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 37202 Quantity | 0 SEK | Current |
| 2026-05-13 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Disposal | Egetis Therapeutics AB BTA Share · SE0017770027 | 158928 Quantity | 6.5 SEK | Revised |
| 2026-05-13 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 286071 Quantity | 6.5 SEK | Current |
| 2026-05-11 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 264880 Quantity | 0 SEK | Revised |
| 2026-05-11 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 529761 Quantity | 0 SEK | Current |
| 2026-05-13 | Henrik Krook Other member of the company's administrative, management or supervisory body | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 264880 Quantity | 6.5 SEK | Current |
| 2026-05-11 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 264880 Quantity | 0 SEK | Current |
| 2026-05-13 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 119529 Quantity | 6.5 SEK | Current |
| 2026-05-13 | Yilmaz Mahshid Chief Financial Officer (CFO) | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 153631 Quantity | 6.5 SEK | Current |
| 2026-05-11 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 265620 Quantity | 0 SEK | Current |
| 2026-05-11 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 264880 Quantity | 0 SEK | Current |
| 2026-01-14 | Mats Blom Chairman of the Board of Directors | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 150000 Quantity | 4.48 SEK | Current |
| 2025-11-28 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 25000 Quantity | 4.79 SEK | Current |
| 2025-11-28 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 25000 Quantity | 4.73 SEK | Current |
| 2025-11-28 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 5000 Quantity | 4.86 SEK | Current |
| 2025-11-27 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 25000 Quantity | 4.58 SEK | Current |
| 2025-11-26 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 60000 Quantity | 3.8711 SEK | Current antal aktier har korrigerats |
| 2025-11-26 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 232266 Quantity | 3.8711 SEK | Revised |
| 2025-11-27 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 15000 Quantity | 4.773 SEK | Current Korrigerat pris per enhet för handeln 2025-11-26 |
| 2025-11-27 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 15000 Quantity | 4.773 SEK | Revised |
| 2025-11-26 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 60000 Quantity | 4.114 SEK | Current Korrigerat pris per enhet för handeln 2025-11-26 |
| 2025-11-26 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 60000 Quantity | 4.246 SEK | Revised |
| 2025-11-26 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 25000 Quantity | 3.94 SEK | Current |
| 2025-11-26 | Mats Blom Chairman of the Board of Directors | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 35000 Quantity | 4.29 SEK | Current Felstavning |
| 2025-11-26 | Mats Blom Chairman of the Board of Directors | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 35000 Quantity | 4.29 SEK | Revised |
| 2025-11-25 | Mats Blom Chairman of the Board of Directors | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 180000 Quantity | 5.24 SEK | Current Felstavning |
| 2025-11-25 | Mats Blom Chairman of the Board of Directors | Acquisition | Egetis Therapeuics Share · SE0003815604 | 180000 Quantity | 5.24 SEK | Revised |
| 2025-07-15 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 35000 Quantity | 5.38 SEK | Current |
| 2025-06-05 | Laetitia Szaller Other member of the company's administrative, management or supervisory body | Acquisition | EGTX Share · SE0003815604 | 13460 Quantity | 4.05 SEK | Current |
| 2025-06-05 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 15100 Quantity | 4.05 SEK | Current |
| 2025-06-04 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 32742 Quantity | 3.93 SEK | Current |
| 2025-06-02 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 15000 Quantity | 3.43 SEK | Current |
| 2025-06-02 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 15000 Quantity | 3.42 SEK | Current |
| 2025-06-02 | Karl Hård af Segerstad Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 38240 Quantity | 3.37 SEK | Current |
| 2025-01-09 | Yilmaz Mahshid Chief Financial Officer (CFO) | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 39753 Quantity | 6.75 SEK | Current |
| 2025-01-08 | Yilmaz Mahshid Chief Financial Officer (CFO) | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 98567 Quantity | 6.63 SEK | Current |
| 2025-01-07 | Yilmaz Mahshid Chief Financial Officer (CFO) | Disposal | Egetis Therapeutics AB Share · SE0003815604 | 74769 Quantity | 6.79 SEK | Current |
| 2024-11-08 | Henrik Krook Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 65000 Quantity | 4.31 SEK | Current |
| 2024-11-08 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 3000 Quantity | 4.22 SEK | Current |
| 2024-11-08 | Christian Sonesson Other member of the company's administrative, management or supervisory body | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 3000 Quantity | 4.12 SEK | Current |
| 2024-10-07 | Yilmaz Mahshid Chief Financial Officer (CFO) | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 10000 Quantity | 4.225 SEK | Current |
| 2024-10-07 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 10142 Quantity | 4.25 SEK | Current |
| 2024-02-23 | Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory | Acquisition | Egetis Therapeutics AB Share · SE0003815604 | 19600 Quantity | 6.1 SEK | Current |
3748 publication days captured; dates between 2016-07-03 and 2026-10-08 may contain gaps. Checked 2026-10-08 22:11 UTC.